Primary peripheral nodal lymphoma in children

Area of Science:

• Pediatric Oncology
• Hematology
• Cancer Research

Background:

• Study analyzed 208 pediatric patients with non-Hodgkin lymphoma (NHL) between 1971-1986.
• 84 patients (40.4%) had nodal lymphomas, including 40 with peripheral nodal lymphoma and 44 with mediastinal lymphoma.

Purpose of the Study:

• To evaluate the treatment outcomes and survival rates for pediatric patients with primary peripheral nodal lymphoma.
• To assess prognostic factors influencing survival in this patient group.

Main Methods:

• Retrospective analysis of 40 pediatric patients with primary peripheral nodal lymphoma treated with the LSA2-L2 protocol (1971-1986).
• Data collected on patient demographics, disease stage, lymphoma subtype, treatment received, and survival outcomes.
• Statistical analysis to determine the significance of prognostic factors such as sex, age, stage, and LDH levels.

Main Results:

• The event-free survival rate was 75%, and the lymphoma-free survival rate was 80%.
• Sex, age, and stage were not significant prognostic factors.
• Aggressive treatment, including radiation therapy and dose-intensive chemotherapy, positively influenced survival by promoting cell kill and preventing resistance.

Conclusions:

• Primary peripheral nodal lymphoma in children, though often disseminated at diagnosis, is highly curable with aggressive treatment.
• A 75% lymphoma-free survival rate in patients with marrow involvement demonstrated the efficacy of this approach.
• These findings informed the development of new treatment philosophies for high-risk leukemias and lymphoma-leukemias.